Type | Filed | Filer | Subject | Shares Owned | Percent Owned | |
---|---|---|---|---|---|---|
SC 13D/A | 2015-03-04 | VENKATARAMAN BALAJI | Horizon Pharma plc | 4,586,317 | 3.7% | EDGAR |
SC 13G/A | 2015-02-17 | Broadfin Capital, LLC | Horizon Pharma plc | 8,917,975 | 7.5% | EDGAR |
SC 13G/A | 2015-02-17 | Flynn James E | Horizon Pharma plc | 11,699,047 | 9.8% | EDGAR |
SC 13G/A | 2015-02-17 | Boehringer Christoph | Horizon Pharma plc | 3,250,000 | 2.7% | EDGAR |
SC 13G | 2015-02-17 | KINGDON CAPITAL MANAGEMENT, L.L.C. | Horizon Pharma plc | 6,374,616 | 5.4% | EDGAR |
SC 13G/A | 2015-02-13 | SUTTER HILL VENTURES | Horizon Pharma plc | 3,272,419 | 2.6% | EDGAR |
SC 13G/A | 2015-02-12 | ATLAS VENTURE FUND VI LP | Horizon Pharma plc | 3,386,898 | 2.8% | EDGAR |
SC 13G/A | 2015-02-12 | Visium Asset Management, LP | Horizon Pharma plc | 4,497,065 | 3.8% | EDGAR |
SC 13D/A | 2014-11-17 | VENKATARAMAN BALAJI | Horizon Pharma plc | 10,499,360 | 8.8% | EDGAR |
SC 13D/A | 2014-09-23 | Vidara Therapeutics Holdings LLC | Horizon Pharma plc | 0 | 29.5% | EDGAR |
SC 13D | 2014-09-23 | VENKATARAMAN BALAJI | Horizon Pharma plc | 16,586,317 | 15.6% | EDGAR |
SC 13D | 2014-09-22 | Vidara Therapeutics Holdings LLC | Horizon Pharma plc | 31,350,000 | 29.5% | EDGAR |
SC 13G/A | 2014-08-07 | Quaker BioVentures II LP | HORIZON PHARMA, INC. | - | - | EDGAR |
SC 13G | 2014-08-07 | Visium Asset Management, LP | HORIZON PHARMA, INC. | 3,969,962 | 5.3% | EDGAR |
SC 13G | 2014-05-01 | SUTTER HILL VENTURES | HORIZON PHARMA, INC. | 3,296,728 | 5.0% | EDGAR |
SC 13D | 2014-03-28 | Vidara Therapeutics International Ltd | HORIZON PHARMA, INC. | 12,051,301 | 17.6% | EDGAR |
SC 13D/A | 2014-03-19 | Discovery Group I, LLC | HORIZON PHARMA, INC. | 3,252,626 | 4.8% | EDGAR |
SC 13D/A | 2014-03-03 | Discovery Group I, LLC | HORIZON PHARMA, INC. | 4,174,909 | 6.3% | EDGAR |
SC 13G/A | 2014-02-14 | Broadfin Capital, LLC | HORIZON PHARMA, INC. | 4,257,469 | 6.5% | EDGAR |
SC 13G/A | 2014-02-14 | Boehringer Christoph | HORIZON PHARMA, INC. | 4,157,575 | 6.3% | EDGAR |